1
|
Sammour YM, Anwaar MF, Cabral-Amador F, Garcia J, Aoun J, Kazmi S, Faza N, Little SH, Reardon MJ, Kleiman NS, Goel SS. Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence. Heart Int 2024; 18:24-36. [PMID: 39885934 PMCID: PMC11781372 DOI: 10.17925/hi.2024.18.2.4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2024] [Accepted: 10/16/2024] [Indexed: 02/01/2025] Open
Abstract
Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.
Collapse
Affiliation(s)
- Yasser M Sammour
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Muhammad Faraz Anwaar
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Francisco Cabral-Amador
- Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA
| | - Jian Garcia
- Department of Internal Medicine, University of Texas Rio Grande Valley, Weslaco, TX, USA
| | - Joe Aoun
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Sana Kazmi
- Department of Internal Medicine, Dow Medical College, Karachi, Pakistan
| | - Nadeen Faza
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Stephen H Little
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Michael J Reardon
- Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, United States
| | - Neal S Kleiman
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| | - Sachin S Goel
- Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
| |
Collapse
|
2
|
Vinayak M, Prandi FR, Safi L, Sharma A, Tang GHL, Lerakis S, Kini AS, Sharma SK, Pinney S, Lala A, Khera S. Secondary Mitral Regurgitation: Updated Review with Focus on Percutaneous Interventional Management. J Card Fail 2024; 30:1302-1318. [PMID: 39389742 DOI: 10.1016/j.cardfail.2024.06.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Revised: 05/26/2024] [Accepted: 06/10/2024] [Indexed: 10/12/2024]
Abstract
Secondary mitral regurgitation (SMR) is associated with increased mortality and heart failure hospitalizations. The management of heart failure patients with SMR is complex and requires a multidisciplinary Heart Team approach. Guideline-directed medical therapies remain fundamental, yet in a proportion of patients SMR persists. In the past decade, transcatheter edge-to-edge repair (TEER) has been shown to improve survival in patients with SMR who remain symptomatic despite medical therapy. Technical advancements across newer generations of devices, improved imaging, and greater operator expertise have collectively contributed to the increased safety and efficacy of this procedure over time. Various emerging transcatheter mitral valve repair and replacement devices are currently under investigation and may offer superior, complementary or synergistic treatment options in patients ineligible for TEER. This review provides a state-of-the-art overview regarding the diagnosis of SMR, and currently available transcatheter mitral valve interventions and describes a contemporary approach to the management of SMR.
Collapse
Affiliation(s)
- Manish Vinayak
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/manishvinayak
| | - Francesca R Prandi
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/prandi_fr
| | - Lucy Safi
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/LucySafi
| | - Anupam Sharma
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Gilbert H L Tang
- Department of Cardiovascular Surgery, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/GilbertTangMD
| | - Stamatios Lerakis
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Annapoorna S Kini
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/DoctorKini
| | - Samin K Sharma
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY
| | - Sean Pinney
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/spinneymd
| | - Anuradha Lala
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY. https://twitter.com/dranulala
| | - Sahil Khera
- Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY.
| |
Collapse
|
3
|
Zahid S, Anjali Garg J, Altibi A, Golwala H. Mitral Transcatheter Edge-to-Edge Repair: Advancing Treatment Options for Degenerative Mitral Regurgitation. Interv Cardiol Clin 2024; 13:155-165. [PMID: 38432759 DOI: 10.1016/j.iccl.2024.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/05/2024]
Abstract
Degenerative mitral regurgitation (DMR) has earned great interest because of modern and innovative technologies emerging in its treatment. MR affects roughly one-tenth of those older adults over the age of 75. MR if untreated leads to adverse heart remodeling, resulting in left ventricular dysfunction, pulmonary hypertension, and heart failure syndrome. Despite surgical valve repair/replacement treatment being the standard of care, a significant proportion of severe MR patients face unmet clinical needs because of high or prohibitive surgical risks. This has led to the emergence of transcatheter therapies for high- and prohibitive-risk surgical patients, most notably mitral transcatheter edge-to-edge repair devices.
Collapse
Affiliation(s)
- Salman Zahid
- Department of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, 3161 SW Pavillon Loop, Portland, OR 97239, USA
| | - Jasmine Anjali Garg
- Department of Medicine, Westchester Medical Center, 100 Woods Road, Valhalla, NY 10595, USA
| | - Ahmed Altibi
- Department of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, 3161 SW Pavillon Loop, Portland, OR 97239, USA
| | - Harsh Golwala
- Department of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, 3161 SW Pavillon Loop, Portland, OR 97239, USA.
| |
Collapse
|